Antiphospholipid syndrome and the idiotypic network

Abstract

To study whether monoclonal anticardiolipin antibodies (aCL), derived from patients with antiphospholipid syndrome (APS). have similar pathogenic potential, we have employed an experimental model of antiphospholipid syndrome.

Monoclonal aCL were produced by the combined method of EBV transformation and somatic cell hybridization of lymphocytes, derived from patients with APS. The monoclonal aCL were used to immunize mice at the footpads and the mice were followed for serological and clinical manifestations of APS.

The monoclonal antibody EY2C9, was found to bind weakly to cardiolipin and other phospholipids (i.e. phosphatidyl-serine, phosphatidyl-ethanolamine and phosphatidyl-inositol). The antibody TM 1B9, although derived from a patient with SLE and with secondary APS, did not react with phospholipids. Immunization of naive BALB/c mice with EY2C9 was followed by production of sustained high titers of antiphospholipid antibodies associated with prolonged activated partial thromboplastin time (APTT) (46.8 ± 5.0 s vs. 22.4 ± 1.7 s, in the non-immunized mice). Mice immunized with TM 1 B9 had a more moderate titer of antiphospholipid antibodies and did not show prolonged APTT. The pregnant mice, that were immunized with EY2C9, had increased fetal resorption rate (the equivalent of fetal loss in the human) of 36.8 ± 10% (vs. 2 ± 4% in mice immunized with TM 1 B9).

Our results confirm that monoclonal aCL, derived from a patient with APS, can have a pathogenic potential, dysregulating the idiotypic network and leading to the development of characteristic signs of APS. Moreover, our findings suggest that immunization with antibody, although non-reactive with what is thought to be the antigen, but derived from a patient with active disease, can still promote the development of related antibodies, probably because it has other characteristics of pathogenicity (i.e. idiotype).

Keywords

anticardiolipin antibodies autoimmunity animal model antiphospholipid syndrome pathogenic antibodies

Get full access to this article

View all access options for this article.

References

Asherson RA A primary antiphospholipid syndrome. J Rheumatol 1987; 15: 1742-1746.

Alarcon-Segovia D. , Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-488.

Hughes Grv , Harris EN , Gharavi AE The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-489.

Lockshin MD Anticardiolipin antibody. Arthritis Rheum 1987: 30: 471-472 (editorial).

Khamashta MA et al. Immune-mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membrane. Ann Rheum Dis 1988: 47: 849-854.

Asherson RA et al. The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine 1989; 68: 366-374.

Tomer Y. et al. Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome. J Rheumatol 1991: 18: 95-97.

Triplett DA Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol 1989; 20: 52-67.

Blank et al. Induction of antiphospholipid syndrome in mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88: 3069-3073.

10.

Mendlovice S. et al. Induction of a systemic lupus erythematosus-like disease in mice by a common anti-DNA idiotype. Proc Natl Acad Sci USA 1988; 85: 2260-2264.

11.

Blank M. et al. The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice. Scand J Immunol 1990 ; 31: 45-52.

12.

Fricke H. et al. Induction of experimental systemic lupus erythematosus in mice by immunization with a monoclonal anti-La autoantibody. Int Immunol 1990; 2: 225-230.

13.

Bakimer R. et al. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992: 89: 1558-1563.

14.

Hohmann A. et al. The H-3 antiphospholipid idiotype is found in patients with SLE but not in patients with syphilis. Clin Exp Immunol 1989 ; 86: 207-211.

15.

Cohen J. et al. Pathogenic serum IgG anticardiolipin antibodies and the idiotypic network. Ann Rheum Dis 1993; 52: 742-748.

16.

Blank M. , Tincani A. , Shoenfeld Y. Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J Rheumatol 1994; 21: 100-104.

17.

Cohen J. et al. Pathogenic natural anticardiolipin antibodies: the experience from monoclonal gammopathy. Clin Exp Immunol 1994; 97: 181-186.

18.

Ichikawa K. et al. β2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome . Arthritis Rheum 1994; 37: 1453-1462.

19.

Teng Nnh et al. Construction and testing of mouse-human heteromyelomas for human monoclonal antibody production. Proc Natl Acad Sci USA 1 983; 80: 7308-7312.

20.

Shoenfeld Y. et al. Production of autoantibodies by human-human hybridomas. J Clin Invest 1982, 70: 205-208.

21.

Zurgil et al. Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis. J Clin Immunol 1991; 11: 239-245.

22.

Roth C. et al. Immune response against poly(Glu60. Ala30. Tyr10) (GAT): immunization with monoclonal anti-idiotypic antibodies leads to the predominant stimulation of idiotypically similar immunoglobulins with anti-GAT activity. Eur J Immunol 1985; 15: 576-580.

23.

Dang H. et al. Induction of lupus-associated autoantibodies by immunization with native and recombinant IgG polypeptide expressing cross-reactive idiotype 4B4. J Immunol 1993 ; 151: 7260-7267.

24.

Fougereau M. et al. The GAT system: a possible germline idiotypic network. In: Reichlin M , Capra JD (eds). Idiotypes. Academic Press , 19 pp.3-16.

25.

Tincani A. et al. Induction of experimental SLE in naive mice by immunization with serum polyclonal anti-DNA antibody carrying the 16/6. Clin Exp Rheumatol 1993; 11: 129- 134.

26.

Pierangeli SS , Harris EN Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human beta 2 glycoprotein or anticardiolipin antibodies alone. Clin Exp Immunol 1993; 93: 269-272.

27.

Stocks MR , Williams DG Maini RR Differential induction of lupus associated anti-nuclear antibodies in MRL mice by monoclonal anti-Sm antibodies. Clin Exp Immunol 1987: 67: 492-499.

28.

Eisenberg RA et al. Regulation of the anti-Sm autoantibody response in SLE mice by monoclonal anti-Sm antibodies. J Clin Invest 1990; 85: 86-92.

29.

Rombach E. , Stetler DA , Brown JC Rabbits produce SLE-like anti-RNA polymerase I and anti-DNA autoantibodies in response to immunization with either human or murine SLE anti-DNA antibodies . Autoimmunity 1992, 13: 291-302.

30.

Asherson RA Shoenfeld Y. The significance of antibodies to DNA in the primary antiphospholipid syndrome. Clin Exp Rheumatol 1994: 12: 1-3.

31.

Harris EN et al.Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985; 16: 1-6.

32.

Smeenk Rjt , Lucassen Wam , Swaak Tjg.

Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity?

Arthritis Rheum 1988; 30: 607-617.